[CH3:1][CH:2]([CH3:10])[CH2:3][CH2:4][C:5](=O)[CH:6]=[CH:7][CH3:8].C1CC=CC=1.Cl(O)(=O)(=O)=O.[CH2:21]([C@@H:28]1N[C@H](C2OC(C)=CC=2)N(C)C1=O)[C:22]1[CH:27]=CC=C[CH:23]=1.[OH2:41]>>[CH3:1][CH:2]([CH3:10])[CH2:3][CH2:4][C:5]([C@@H:6]1[C@@H:21]([CH3:28])[C@@H:22]2[CH2:27][C@@H:7]1[CH:8]=[CH:23]2)=[O:41]Prepared according to general procedure A from 7-methyloct-2-en-4-one (82 μL, 0.50 mmol), cyclopentadiene (62 μL, 0.75 mmol), 70% aqueous perchloric acid (8.6 μL, 0.10 mmol) and (2S, 5S)-5-benzyl-3-methyl-2-(5-methyl-furan-2-yl)-imidazolidin-4-one (27 mg, 0.10 mmol) in water (167 μL) for 38 hours at 0° C. Purification by silica gel chromatography (19:1 hexanes:ethyl acetate) provided the title compound as a colorless oil in 86% yield (89 mg, 0.43 mmol); 20:1 endo:exo, endo 92% ee. IR (film) 3061, 2957, 2870, 1708, 1462, 1367, 1332, 1269, 1141, 1107, 1064, 904.7, 799.8, 716.2 cm−1; 1H NMR (300 MHz, CDCl3) δ 6.20 (dd, J=5.7, 3.0 Hz, 1H, CH═CH), 5.87 (dd, J=5.7, 2.7 Hz, 1H, CH═CH), 3.11 (m, 1H, CHCH═CH), 2.43 (m, 1H, CHCH═CH), 2.39 (m, 3H, CHCO and CH2CO), 1.86 (m, 1H, CHCH3), 1.58-1.37 (m, 5H, COCH2CH2CH, CHCH2CH), 1.13 (d, J=6.9 Hz, 3H, CH2CH3), 0.86 (d, J=6.3 Hz, 6H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 211.5, 138.6, 132.6, 61.2, 49.3, 46.6,40.0,35.9, 32.9, 28.1, 22.8, 22.7, 21.4; HRMS (CI) exact mass calc'd for (C14H22O) requires m/z 206.1671, found m/z 206.1671. [α]D=+89.4 (c=1.0, CHCl3). Product ratios were determined by GLC analysis (150° C., 23 psi); (1R, 2R, 3S, 4R) endo isomer tr=7.4 min, and (1S, 2S, 3R, 4S) endo isomer tr=7.1 min, exo isomers tr=6.6, 6.8 min.
Wird geladen…
